Search bioRxiv⌕ Search

Biology subjects

Lin, T.-Y.

Publications and source records attributed to Lin, T.-Y..

21 records · Page 2Linked to original sources

Comparing trait syndromes between Taiwanese subtropical terrestrial and epiphytic ferns and lycophytes at the species and community level

Background and AimsWhile functional trait-trait and trait-environment relationships are well studied in angiosperms, it is less clear if similar relationships, such as the leaf economics spectrum (LES), hold for ferns, and whether they differ between terrestrial and epiphytic fern communities. We used vegetation data collected along an elevation gradient in Taiwan to explore these relationships. MethodsWe measured nine leaf traits for 47 terrestrial and 34 epiphytic fern species across 59 vegetation plots along an elevation gradient in the subtropical forest of Northern Taiwan. We explored trait-trait and trait-environment relationships at both the species and community levels for both growth habits, while accounting for phylogenetic relationships. Key ResultsEpiphytes differed from terrestrial ferns in species- and community-level trait values, mainly reflecting responses to higher drought and nutrient stress. The angiosperm LES was reflected in the trait-trait correlations of terrestrial ferns and less expressively in epiphytes. This pattern suggests that mainly water rather than nutrient availability shapes epiphytic trait patterns. Trait-trait analysis on raw trait data and on independent contrasts vary in some ways. Trait-environment relationships were similar for several drought-related traits across both species groups. ConclusionsThis study illustrates that fern trait patterns are not entirely equivalent for epiphytic and terrestrial species or communities and should not be extrapolated across growth habits or between the species and community levels. Phylogenetic constraints may influence the trait-environment response of epiphytic species.

ecology↗

Plasmablast-derived antibody response to acute SARS-CoV-2 infection in humans

Serological and plasmablast responses and plasmablast-derived IgG monoclonal antibodies (MAbs) have been analysed in three COVID-19 patients with different clinical severities. Potent humoral responses were detected within 3 weeks of onset of illness in all patients and the serological titre was elicited soon after or concomitantly with peripheral plasmablast response. An average of 13.7% and 13.0% of plasmablast-derived MAbs were reactive with virus spike glycoprotein or nucleocapsid, respectively. A subset of anti-spike (10 of 32) and over half of anti-nucleocapsid (19 of 35) antibodies cross-reacted with other betacoronaviruses tested and harboured extensive somatic mutations, indicative of an expansion of memory B cells upon SARS-CoV-2 infection. Fourteen of 32 anti-spike MAbs, including five anti-RBD, three anti-non-RBD S1 and six anti-S2, neutralised wild-type SARS-CoV-2 in independent assays. Anti-RBD MAbs were further grouped into four cross-inhibiting clusters, of which six antibodies from three separate clusters blocked the binding of RBD to ACE2 and five were neutralising. All ACE2-blocking anti-RBD antibodies were isolated from two patients with prolonged fever, which is compatible with substantial ACE2-blocking response in their sera. At last, the identification of non-competing pairs of neutralising antibodies would offer potential templates for the development of prophylactic and therapeutic agents against SARS-CoV-2.

microbiology↗

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

The COVID-19 pandemic has had unprecedented health and economic impact, but currently there are no approved therapies. We have isolated an antibody, EY6A, from a late-stage COVID-19 patient and show it neutralises SARS-CoV-2 and cross-reacts with SARS-CoV-1. EY6A Fab binds tightly (KD of 2 nM) the receptor binding domain (RBD) of the viral Spike glycoprotein and a 2.6[A] crystal structure of an RBD/EY6A Fab complex identifies the highly conserved epitope, away from the ACE2 receptor binding site. Residues of this epitope are key to stabilising the pre-fusion Spike. Cryo-EM analyses of the pre-fusion Spike incubated with EY6A Fab reveal a complex of the intact trimer with three Fabs bound and two further multimeric forms comprising destabilized Spike attached to Fab. EY6A binds what is probably a major neutralising epitope, making it a candidate therapeutic for COVID-19.

microbiology↗